Nuclear Warhead Manufacturers and Responders, Wake Up: It's Time to Diversify into Manufacturing and or Developing Bio Weapons and Bio Attack Preparedness and Response Systems
Dr. John Norris is a former FDA COO and Harvard faculty member. He is a successful entrepreneur and expert in risk management for the spread of pathogens from bio attacks, whether nature-made or human-manufactured. He has written over 120 articles and posts on this topic's various aspects, perspectives, and concerns. On behalf of all people everywhere, Dr. Norris and his team have self-funded $1 million in cash and invested over $2 million in sweat equity to create the world’s best infectious disease-spread risk-management platform: VirusVigilant. Their mission is to save up to a million lives by the decade's end. They have their "fingers in the dike." But look to other "US and global patriots" and others to help prepare the US and the globe for imminent bio attacks.
Introduction
In today's rapidly evolving world, national security and defense threats continue to loom large. As technology advances and new challenges arise, it is imperative for nuclear warhead manufacturers and responders to adapt and diversify their capabilities into a new, more prominent, in terms of likelihood of use, category of threat. The traditional focus on nuclear weaponry must now expand to include the manufacturing bio weapons and developing of advanced bio attack preparedness and response systems to combat the spread of infectious diseases. It's the "spread" that kills millions. The time has come to acknowledge the shift in the prevailing threat landscape and take necessary quick action. We assure you that your competitors are already contemplating the financial, competitive, and strategic worth of our previous messages.
Dr. Norris said, The weapon of choice is now an undetectable to-source, small bio weapon, launched stealthfully. It is much more likely to be used than a small or large nuclear weapon. Bio weapons now present the foremost "real and present danger." In the coming years, bio weapons will increasingly replace even the "contemplated and viable threat of use" of nuclear weapons. Nuclear weapons have decreased regarding the likelihood of their use and, therefore, both their actual and apparent risk. As nuclear weapons have become more and more unbelievably destructive, they have, interestingly, in turn, reduced their own value. Only an insane leader would perform a "first strike," something that would immediately be identified as to source and would immediately lead to the complete destruction of the aggressors--and because of treaties on both sides might possibly increase the level of destruction over and over again to the point that it destroyed the world as we know it. No country and their leader's immediate team is going to permit their leader to do this. Leaders and most of their immediate staff likely have living parents, spouses, and children who they value very much.
Post-COVID-19, whether you believe it was nature-made or human-manufactured, that shift in thinking at every level of society--from person to community to region to country to international--is obvious. What is the greatest national security and defense threat that is spoken about at the corporate cooler now? It's the bio threat, not the nuclear threat.
The Changing Face of Security Threats
The threat of nuclear war has long been a cause for concern, prompting governments and defense organizations to build robust weapons and delivery systems to safeguard countries and their people against such catastrophic events. However, for a variety of reasons, in recent years, the threat landscape has shifted, and the use of bio weapons has emerged as a more viable and devastating form of attack by an aggressor. It's the "likelihood of use" that counts. The COVID-19 pandemic is a stark reminder of the havoc that infectious diseases can wreak on societies and economies worldwide.
Dr. Norris said, For example, in this brief article, we will speak about why small bio weapons stealthfully delivered have quietly surpassed small or large nuclear weapons. We all should be concerned about this switch. Bio weapons are able to be structured to be extremely powerful and capable of being delivered with stealth. Both as to content and as to delivery system, they are "a force to be reckoned with". They also are relatively, very much cheaper to develop and deliver. Even small proxy terrorist groups can develop and deliver them on their own, even if the country or countries to which they are aligned will not do these two critical things for them. In other words, they are far more dangerous to enterprises and regions than highly restricted and, therefore, never-to-be-used nuclear weapons in real terms.
Plus, viable threats of use in this category are easy to produce and powerful forces. The threat of the use of nuclear weapons is no longer a viable threat. In life, viable threats take many different forms. There is nothing more scary n the real world, than when you are possibly carrying home to your spouse and children an invisible, hyper-deadly pathogen. The viable threat of nuclear weapon use is no longer at the top of the minds of Americans and the people of most nations. But the viable threat of bio weapon "use" is. It very much is.
The Rise of Bio Weapons, Delivery Systems, and Response Strategies, Plans, Programs, Systems, Tools, and Other Bio Spread Risk Management Mechanisms
Bio weapons, or biological weapons, are defined as weapons that uses disease-causing microorganisms or toxins derived from living organisms to harm or kill humans, animals, or plants. In the latter two, if enough animals or plants are killed or harmed, people die indirectly through starvation. These weapons have the potential to cause widespread devastation, with the ability to spread rapidly and affect larger and larger populations. Unlike nuclear weapons and chemical weapons, their impact grows and grows. It is not a "one and done."
Dr. Norris said, The relative ease of manufacturing and deploying bio weapons compared to nuclear warheads makes them an attractive option for non-state actors and rogue nations. Every enemy of the US and Israel, for example, especially China, appears to be improving the nature of their bio weapons and their bio weapon delivery systems. And they are increasing the stockpiled number of these advanced weapons, of which there are 24 best known and their variants. And they are enhancing the availability and utility of the most potent "conveyance systems," of which there are dozens and dozens of which they are stockpiling. There are so many critical advantages in using bio weapons we cannot list them all in this brief article. But we will examine several.
Perhaps most importantly, since small, stealth bio attacks are all but undetectable as to source, are the enterprise-level and nation-level response strategies, plans, programs, systems, tools, and other bio spread risk management mechanisms. For this part of risk management, there are now a few top-of-line software platform products.
Why Nuclear Warhead Manufacturers and Responders Should Diversify
There are many reasons why nuclear warhead manufacturers and responders should now begin to diversify. Here are four of the most significant ones:
Addressing the Real and Present Danger: As evidenced by the death of 1.2 million Americans during the COVID-19 pandemic attack, whether you believe it was nature-made or human-manufactured, the threat of a bio attack is no longer a hypothetical scenario but a tangible and immediate concern. Today, a small bio attack using a highly dangerous pathogen stealthfully delivered is more fearsome than a small or large nuclear attack. Accordingly, it is crucial for nuclear warhead manufacturers and responders to recognize this shifting threat landscape and adapt accordingly. Those who do not adapt to changing business environments can suffer serious growth, revenue, and profit declines.
Utilizing Existing Infrastructure: Nuclear warhead manufacturers and responders possess the necessary infrastructure, expertise, and resources to pivot towards manufacturing bio weapons and response systems at all levels. By leveraging their existing capabilities, these organizations can play a crucial role in mitigating the threat posed by bio weapons--both in terms of its use and in terms of the viable threat of its use, which can be almost as devastating mentally, psychologically, and financially, both of which could destroy people and economies.
Diversification and Economic Viability: Diversifying into the manufacturing of bio weapons and response systems presents a significant economic opportunity for these organizations. As the demand for bio-defense systems and technologies increases, there is immense potential for growth and profitability in this sector. Any CEO and or COO who is blind to this massive diversification opportunity will be replaced when their competitors do.
Enhancing National Security and Defense: By expanding their capabilities to include bio weapons and response systems, nuclear warhead manufacturers and responders contribute to strengthening national security and defense, which is a good thing for everyone, including them. They can collaborate with governments and defense organizations to develop comprehensive strategies and technologies to counter the bio attack threat effectively. They already have government contacts and can educate and incentivize politicians, government agency heads, and workers, as well as us patriots who care about our country, to jump aboard this boat before it leaves the docks with only their competitors aboard.
Building Bio Weapons Manufacturing Capacity
To successfully diversify into the manufacturing of bio weapons, several essential steps must be taken:
Investment in Research and Development: Nuclear warhead manufacturers and responders should allocate significant resources to research and development efforts focused on bio weapon manufacturing and responding technologies. This includes creating or adopting advancements in (1) genetic engineering, (2) synthetic biology, (3) vaccine, testing, and therapeutics development, and (4) systems and responder risk management software development—or partnering with the best in these fields while they might still be available and not already pledged to a competitor.
Establishing Deep Collaborations: Existing deep collaborative partnerships between (1) nuclear warhead manufacturers, (2) academic institutions, (3) research laboratories, and (4) entrepreneurs (from where most innovations come) can foster transformative innovation, insights, and knowledge-sharing. These collaborations will enable warhead manufacturing organizations to leverage the expertise of various stakeholders and accelerate the development of bio weapon manufacturing capabilities.
Strict Regulatory Frameworks: The manufacturing and deployment of bio weapons necessitate stringent regulations and oversight to prevent misuse. Nuclear warhead manufacturers must work with governments and international bodies to establish robust regulatory frameworks that ensure safety and prevent proliferation. They have the regulatory skills in-house or under contract with top regulatory firms or partners These same regulatory firms already have sufficient bio-related regulatory expertise or can create or expand it. Or the bio attack spread risk management companies with which they partner might have significant amounts of related health, healthcare, and manufacturing regulatory experience and expertise in-house or within their regulatory firms or partners.
Training and Education: Organizations must invest in training and educating their workforce to adapt to the new field of bio weapon manufacturing. This includes developing specialized training programs and fostering collaboration between experts in both nuclear and biological fields. This training would be exciting to their workforce and easy to perform. Most of their workforce already knew "that this day would come," and they will be happy that their company is among the first to begin diversifying in the bio direction--both career-wise and protection of self and family-wise, as well as pride and love toward their country in the form of patriotism-wise.
Developing Bio Weapon Response Systems
Alongside manufacturing bio weapons, nuclear warhead manufacturers and responders must also focus on building robust response systems to counter bio attacks. These response systems include preparedness to respond during an attack, using "in-crisis adaptable responses" as conditions change. This will be done using advanced, transformative strategies, plans, programs, systems, tools, and other deadly pathogen spread risk management mechanisms. Software platform products capable of doing this have already been developed. Partnering with one of these companies before they all are taken by a competitor makes critical financial sense.
Here are some key strategies for developing effective response preparedness and "in-crisis adaptable response" systems to prevent, mitigate, and or control the pathogenic spread:
Developing (or Partnering Regarding) Advanced Surveillance and Early Warning Systems: Develop advanced surveillance and early warning systems to detect and monitor infectious disease outbreaks. This includes investing in cutting-edge technologies for real-time data collection and analysis. Partnering opportunities are also available. Such systems can cover over 24 existing and most prominent infectious diseases, their major variants, and all the factors associated with them. For a large customer, this will require over a million analyses per day and can not be done by hand or even with a staff of 10s of HR professionals.
Vaccine Development: Collaborate with pharmaceutical companies, research institutions, and government agencies to expedite the development and production of vaccines against known and emerging pathogens. Emphasis should be placed on developing vaccines that can be rapidly deployed in the event of a bio attack and can be restructured quickly to cover key variants or even similar diseases. The US was able to cut some 90% of the standard science and regulatory time and effort from the equation during the COVID-19 crisis. The goal would be the same for addressing the next bio attack crisis.
Medical Infrastructure: Invest in the establishment and enhancement of medical infrastructure to respond to large-scale outbreaks. This includes lobbying to support expanding healthcare facilities, stockpiling essential medical supplies, and training healthcare professionals to handle biosecurity threats so they remain well enough to treat patients who present to their enterprise. Your responder products would be of greater value if you did. Plus, you would be flooded with public praise. There is nothing more valuable to the soul and the success of a business than public praise. It is likely that new customers, investors, and workers would flock to you, and your existing ones would stay.
Public Awareness and Education: Engage in public awareness campaigns to educate the general population, workers, families, politicians, executives, media heads, and other leaders and influencers, such as foundation heads, about bio threats and preventive measures. This includes disseminating accurate information, debunking myths, and promoting responsible behavior during preparedness to respond and responding during ever-changing outbreaks.
Conclusion
As the threat landscape continues to evolve away from nuclear and toward bio, nuclear warhead manufacturers and responders must adapt and diversify their capabilities. The manufacturing of top-grade bio weapons and the development of powerful and thoughtful response systems to combat infectious disease spread are crucial components of national security and defense in the modern era. By capitalizing on their existing infrastructure, expertise, and resources, these organizations can play a vital role in countering emerging bio threats. It's time for nuclear warhead manufacturers and responders to expand their horizons and safeguard themselves, us, and their investors, as well as their other partners, from the real and present danger posed by bio attacks. We must do it now. Putting it off is not good for the current manufacturers and responders. Worse, the train is about to leave the station with only their competitors aboard.
A Public Service Announcement by Safely2Prosperity and Its Executive Chairman, Dr. John Norris
We are pleased to often cover the well-hidden story of bio attack reckless unpreparedness as a public service for the sake of our readers and all the people of the US and the world. We aim to have informed, educated, and committed leaders in the US and worldwide at all levels of society. We hope they buy our solution because it is the best. But if not, they must purchase "a" solution. Three alternative solutions are almost as good as Safely2Prosperity’s (S2P's) VirusVigilant. Our mission is to save up to a million lives by the end of the decade.
S2P provides a "comprehensive infectious-disease spread risk-management solution," VirusVigilant, for politicians, business executives, government-agency heads, and other nation leaders to protect their people, employees, families, investors/taxpayers, and others. S2P's VirusVigilant "Infectious Disease Safety Program" (like a now-ubiquitous "Fire Safety Program" but much more sophisticated and complex) combines a SaaS platform with customized risk management tools (AI is to be added soon) for overseeing add-on packages of vaccinations, testing, therapeutics, isolation (if infected), quarantining (if exposed), and tracking technologies, among many others, for up to 24 infectious diseases and their most significant variants.
These tools help such leaders meet their moral, ethical, and legal responsibilities while protecting and enhancing population, workforce, family, and investor/taxpayer safety and productivity. Thereby, VirusVigilant helps assure (it's not "insurance," but "assurance," for leaders, so "they can sleep at night") at 1,000 times less the cost (Yes, 1,000 times less) than health insurance, high levels of (1) business continuity, (2) revenue, (3) profits, (4) investor and insurer financial protection, and (5) the overall effectiveness and survival of the enterprise and its workers, families, and investors/taxpayers. With a focus on proactive measures, S2P offers a cost-effective, low-cost (as low as pennies per employee per month), intuitive solution for risk-managing infectious disease spread. "It's the “spread” that kills millions."
Dr. John Norris is a former FDA COO and Harvard faculty member. He is also a successful entrepreneur recognized as an expert in preventing, mitigating, controlling, and otherwise risk-managing the "spread" of infectious diseases. He has often published on this or related topics in a wide variety of publications, including as editor-in-chief of two academic journals, one at Harvard (the most successful publication of its kind worldwide, which he founded at Harvard some 50 years ago) and the other at Cornell. And gave many presentations on the need for change in health and healthcare systems, including some 300 presentations worldwide. Also, he helped reform the "regulatory procedures" used by the Joint Commission (which "regulates" hospitals, clinics, and nursing homes and the services they provide) and the US FDA (which regulates drug and medical device developers and the products they develop). Finally, he is a successful businessperson and entrepreneur. He and his former teammates sold one of their last start-ups for almost $2 billion in today's dollars.
As the historically world-renowned diplomat Benjamin Franklin said as he signed the US Declaration of Independence from England (the first, most costly, and most dangerous step in forming the United States as a country, but a critical step): "Gentlemen [and Ladies], we must all hang together, or, most assuredly, we shall all hang separately." Thoughtful and aggressive "preparedness" is the first and most essential step in protecting our people and those of our allies from the devastation of a bio attack by a terrorist group, such as Hamas, Hezbollah, or Lebanon, or a hostile nation, such as Iran or North Korea.
Preparedness costs as little as 60 cents per employee per month (again, 1,000th the monthly cost of health insurance). Yet bio attack risk management might prove far more valuable to nations, government agencies, employers, workers, families, and investors--and eventually in far more demand across the board. Therefore, politicians and other leaders who desire to retain their jobs will want to ensure such creative and transformative innovations are always in place and fully operational. Any leader who fails to protect those for whom they are responsible from the ghastly physical, mental, psychological, and financial damage of a bio attack is likely to be found negligent or, worse, “reckless." No leader at any level of society can survive if they are found to be the latter.
If you want to learn more about VirusVigilant, please get in touch with Dr. John Norris by text at 617-680-3127 or by email at John.Norris@Safely2Prosperity.com (mailto:John.Norris@Safely2Prosperity.com). S2P's website is safely2prosperity.com (http://safely2prosperity.com/).
© 2024 Safely2Prosperity LLC and Dr. John Norris, Executive Chairman. ALL RIGHTS RESERVED.
Kommentare